Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Experts publish new guidance on the use of portable MRI exams

The checklist was created to walk researchers through every operational step of using portable MRI, from creating protocols to prepping patients, ensuring patient safety, handling incidental findings, data privacy and more. 

AI-based 3D CTA reconstruction solution scores FDA clearance

Using the new solution, CTA recons are completed in a matter of minutes, not hours.

Banner ASC in Sun City, Arizona.

GE Healthcare investing $138 million to bolster contrast supply

It is estimated that the demand for contrast-enhanced imaging could double over the next decade. 

Medical imaging trends to watch in 2025

The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025. 

Female Medical Research Scientist Working with Brain Scans

New findings prompt experts to call for routine brain imaging of certain breast cancer patients

New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed. 

Jessica H. Porembka, MD, FSBI, associate professor, breast imaging division University of Texas Southwestern Medical Center, Dallas, and vice chair of strategy and quality, and quality assurance medical director, Parkland Radiology in Dallas, explains how an ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective.

Ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective

Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency. 

New radiotracers outperform FDA-approved agent for detection of tau tangles.

Radiotracers on FDA’s fast track exceed performance of already approved tau-detecting agent

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.

Tembo Embolic System

New interventional embolotherapy system lands FDA clearance

The bioresorbable agent is made from small irregularly shaped, dry gelatin particles designed for the embolization of hypervascular tumors and blood vessels. 

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.